Accepted Manuscript of Flaxseed enhances the beneficial effect of low-dose estrogen therapy at reducing bone turnover and preserving bone microarchitecture in ovariectomized rats
aBMD and strength after chronic treatments (12 weeks) in our previous study (Sacco et al. 116 2009). To complement these findings we also included structural analysis of LV -surrogate 117 measure of bone fragility -from a longer-term study (12 the pellets were placed subcutaneously in the interscapular region while rats were anesthetized 153 with isoflurane (3%) dissolved in oxygen with a flow rate of 1 liter per minute. Buprenorphine 154 (0.05 mg/kg body weight) was administered subcutaneously following surgery. Fresh diet was 155 provided bi-weekly. Diets were consumed ad libitum since a previous study showed that ad 156 libitum and pair feeding resulted in similar effects to bone health in ovariectomized rats of a 157 similar age as the present study (Jiang et al. 2008 ). After two weeks of treatment, rats were 158 euthanized using CO 2 asphyxiation followed by cervical dislocation. The two-week study 159 duration was chosen because treatment-induced effects on markers of bone metabolism occur 160 rapidly in rat blood and skeletal tissue (Wronski et al. 1988; Zhang et al. 2007 ) and may explain 161 the differences observed in aBMD by dual energy x-ray absorptiometry (DEXA) and strength 162 after chronic treatments (Sacco et al. 2009 ). Blood was obtained by cardiac puncture and serum 163 aliquots were stored at -80ºC. LV5 were removed, cleaned of soft tissue, fixed in 10% buffered 164 formalin for 24 hours, then stored at -20°C in 100% ethanol for histochemical analyses. 165
166

Study 2 Experimental Design 167
This study was as described previously (Sacco et al. 2009 ). Briefly, OVX (n=48) and sham rats 168 (POS, n=12) were acclimatized for one week on the BD, after which the rats were randomized 169 into the same groups as described for Study 1 except they received the interventions for 12 170 instead of 2 weeks. Food intake was measured daily and body weights were recorded weekly. 171
Total food intake and body weight are reported in Sacco et al (2009) . LV5 were removed, 172 cleaned of soft tissue, and stored at -80°C until scanning of three-dimensional trabecular bone 173 microarchitecture using microcomputed tomography. In contrast to LV, structure of femur and 174 tibia was not determined since both strength and aBMD values were similar among all OVX 175 groups in our previous results (Sacco et al. 2009 ). The lack of response of these long bones may 176 be due to their greater proportion of cortical bone that is less metabolically active compared to 177 trabecular bone that predominates in LV. aBMD and bone strength of femurs, tibias and lumbar 178 vertebra were previously published (Sacco et al. 2009 ). 179
180
Serum Markers of Bone Turnover 181
To assess markers of bone resorption, serum levels of tartrate-resistant acid phosphatase-5β 182 (TRAP-5β), C-terminal telopeptides of type I collagen (CTX), osteoprotegerin (OPG) and 183 RANKL were measured. RANKL is a cytokine that stimulates osteoclast formation, activity and 184 survival while the cytokine OPG acts as a decoy receptor for RANKL (Khosla 2001 Austin, TX, USA). The lowest limit of detection was 1.6 pg/mL. The intra-assay coefficient of 198 variation for osteocalcin was 0.30-0.87%. 199
To assess the OPG-RANKL-RANK axis, serum levels of OPG and RANKL were 200 measured using two Rat OPG-Single Plex and two Rat RANKL-Single Plex kits from Millipore 201 with Luminex™ multiplex reagents according to the manufacturer's instructions. Data were 202 collected using Luminex 100. The lowest limit of detection was 2.3 pg/mL for OPG and 1.0 203 pg/mL for RANKL. The intra-assay coefficients of variation for OPG and RANKL were 1.01-204 2.60% and 2.68-5.04%, respectively, and the inter-assay coefficients of variation for OPG and 205 RANKL were 16.07% and 9.67%, respectively. The OPG/RANKL ratio was then determined 206 based on serum levels of OPG and RANKL for each rat. ). Moreover, the separation between trabeculae appeared to be greater in the NEG group 316 compared to the POS group ( Figure 2B) . 317 318 TRAP-5β: There was a trend for FS+LD to have higher TRAP-5β than NEG (p=0.08) (Figure  319 3A). Moreover, FS+LD and LD and had similar expression of TRAP-5β which also did not 320 differ compared to the POS group, while FS was similar to the NEG group ( Figure 3A) . Greater 321 staining for TRAP-5β was observed in the POS group compared to the NEG group (p<0.01) 322
( Figure 3A, Figure 3B) . 323
324
Osterix: FS+LD, FS, and LD resulted in higher osteoblast expression of osterix compared to the 325 NEG group (p<0.05), and did not differ from the POS group ( Figure 3C ). Osteoblast expression 326 of osterix was higher in POS compared to the NEG group (p<0.05) ( Figure 3C , Figure 3D ). 327 
STUDY 2 342
Bone Microarchitecture at 12 Weeks Post-Ovariectomy 343
The trabecular microarchitecture of LV5 was evaluated at the end of the twelve week study 344 ( Figure 5A ). FS+LD resulted in higher BV/TV compared to both the NEG (p<0.05) and FS 345 (p<0.01) groups and there was a trend for FS+LD to be higher than the LD group (p=0.06) 346 ( Figure 5B). The POS group resulted in the highest BV/TV compared to all other groups 347 (p<0.05), while no other differences were observed ( Figure 5B ). FS+LD resulted in higher 348 (p<0.01) Tb.N compared to the NEG, FS and LD groups and did not differ from the POS group 349 while the LD group resulted in higher (p<0.05) Tb.N compared to the NEG and FS groups 350 ( Figure 5C ). Like all other groups, FS+LD did not modulate Tb.Th ( Figure 5D However, it is difficult to compare our current findings with these previous 381 studies since they were conducted in various clinical populations (e.g., healthy postmenopausal 382 women, middle-aged men) and animal models (e.g., growing mice and gilts), and they were of 383 varying durations (6 weeks-12 months). Nevertheless, the present study demonstrated that a 10% 384 FS diet results in higher serum levels of OPG with no differences in RANKL or the ratio of OPG 385
to RANKL compared to the NEG group. the actions of FS+LD and LD on the vertebra in OVX rats. In addition, since differences in 400 vertebral microarchitecture were already observed after two weeks of treatment in the current 401 study, it may be that differences in markers of bone turnover were more pronounced closer to the 402 initiation of the treatments as observed in previous work (Casari et al. 1997 ). Nevertheless, while 403 serum biochemical markers of bone turnover are useful for the prediction of bone loss during the 404 early stages post-OVX and for monitoring the effectiveness of antiresorptive treatments, they 405 reflect bone turnover of the whole skeleton rather than specific skeletal sites (Seibel 2000) . Thus, 406 TRAP-5β, osteocalcin, OPG and RANKL staining was also performed in LV as this skeletal site 407 experienced the greatest protection to bone microarchitecture in the present study, as well as 408 greater preservation of aBMD and strength in our previous study (Sacco et al. 2009 ). Protein 409 expression of osterix was also determined through histochemical staining of LV since it is 410 expressed in osteoblast cells (Nakashima et al. 2002) and thereby can provide an indication of 411 the differences in osteoblast numbers between groups. Semi-quantitative analysis at the LV 412 demonstrated that while FS+LD induces higher osterix expression compared to the NEG and FS 413 groups, it did not differ from the LD group. This suggests that the enhanced protection to LV 414 bone mass, structure and strength observed when FS is combined with LD compared to LD alone 415 (Sacco et al. 2009 ) may not be due to the modulation of osteoblast numbers. Instead, FS+LD 416 resulted in an osteocalcin score that was significantly lower than the NEG group while LD did 417 not. Furthermore, FS+LD resulted in an OPG score that was significantly higher than the NEG 418 group while LD did not. 419
When comparing the changes in markers of bone metabolism in serum and LV, there 420 were inconsistencies for some markers but consistency with others. These differences are likely 421 due to differences in tissue-specific responses of different skeletal sites but may also be due to 422 methodological differences. For example, FS resulted in higher serum OPG levels compared to 423 NEG while no differences in OPG in LV were observed. LD and FS+LD also induced greater 424 effects in the serum than in the LV. However, FS+LD maintained its stimulatory effect on OPG 425 and inhibitory effect on osteocalcin compared to NEG in LV. 
